Quest Diagnostics Inc. earnings per share and revenue
On Oct 21, 2025, DGX reported earnings of 2.60 USD per share (EPS) for Q3 25, beating the estimate of 2.52 USD, resulting in a 2.81% surprise. Revenue reached 2.82 billion, compared to an expected 2.76 billion, with a 1.89% difference. The market reacted with a -3.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of 2.38 USD, with revenue projected to reach 2.78 billion USD, implying an decrease of -8.46% EPS, and decrease of -1.23% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
DaVita Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$3.18
Actual
$3.40
Surprise
+6.68%
FAQ
What were Quest Diagnostics Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Quest Diagnostics Inc. reported EPS of $2.60, beating estimates by 2.81%, and revenue of $2.82B, 1.89% above expectations.
How did the market react to Quest Diagnostics Inc.'s Q3 2025 earnings?
The stock price moved down -3.03%, changed from $190.41 before the earnings release to $184.64 the day after.
When is Quest Diagnostics Inc. expected to report next?
The next earning report is scheduled for Feb 10, 2026.
What are the forecasts for Quest Diagnostics Inc.'s next earnings report?
Based on 18
analysts, Quest Diagnostics Inc. is expected to report EPS of $2.38 and revenue of $2.78B for Q4 2025.